US Patent 12103926 Compounds for treating huntington's disease
Patent 12103926 was granted and assigned to PTC Therapeutics, Inc. on October, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12103926 Compounds for treating huntington's disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
